The synthetic hallucinogen, 2C-B, that has been marketed in Latin American and Caribbean regions as “cocaina rosada” could potentially cause a range of undesirable outcomes.Medications marketed as “pink copyright” may well incorporate any number of medicine and additives effective at causing moderate to serious outcomes on overall health.Th